Clorox (NYSE:CLX) Director Pierre Breber Purchases 4,000 Shares of Company Stock

Key Points

  • Director Pierre Breber bought 4,000 Clorox shares at an average of $100.06, spending about $400,240 and increasing his stake by 22.2% to 22,000 shares.
  • Clorox reported quarterly EPS of $1.55, beating the $1.07 consensus, while revenue rose 33.3% year over year to $1.91 billion.
  • The company declared a quarterly dividend of $1.25 per share, equivalent to a 5.0% yield; its payout ratio is about 90%. Analyst sentiment overall remained cautious, with a consensus “Reduce” rating.

The Clorox Company (NYSE:CLX - Get Free Report) Director Pierre Breber acquired 4,000 shares of the stock in a transaction on Wednesday, November 4th. The stock was bought at an average price of $100.06 per share, for a total transaction of $400,240.00. Following the transaction, the director owned 22,000 shares in the company, valued at approximately $2,201,320. This represents a 22.22% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

Clorox Price Performance

Shares of NYSE CLX opened at $99.64 on Friday. The stock has a market capitalization of $12.07 billion, a price-to-earnings ratio of 15.89, a PEG ratio of 3.22 and a beta of 0.59. The Clorox Company has a 12 month low of $79.12 and a 12 month high of $128.90. The firm's 50 day simple moving average is $87.79 and its 200-day simple moving average is $99.72. The company has a debt-to-equity ratio of 32.91, a current ratio of 0.65 and a quick ratio of 0.38.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.48. Clorox had a net margin of 9.41% and a return on equity of 608.30%. The firm had revenue of $1.91 billion during the quarter, compared to analyst estimates of $1.88 billion. During the same period in the previous year, the firm earned $0.85 EPS. The business's quarterly revenue was up 33.3% on a year-over-year basis. Analysts expect that The Clorox Company will post 5.78 EPS for the current year.

Clorox Dividend Announcement




The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Wednesday, October 28th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 5.0%. The ex-dividend date is Wednesday, October 28th. Clorox's dividend payout ratio (DPR) is currently 89.93%.

Clorox News Roundup

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Director Pierre Breber bought 4,000 shares for about $400,240, increasing his stake by 22.2% to 22,000 shares. The purchase may signal confidence in Clorox’s outlook. SEC filing
  • Positive Sentiment: JPMorgan and UBS analysts said Clorox’s stock is expected to rise, adding to the positive analyst sentiment. JPMorgan analyst report UBS analyst report
  • Positive Sentiment: Evercore upgraded Clorox’s stock rating, another supportive signal from analysts. Evercore rating report
  • Neutral Sentiment: Morgan Stanley raised its price target from $87 to $94 but kept an “equal weight” rating; the new target remained below the referenced share price. Morgan Stanley rating information
  • Negative Sentiment: Clorox’s margin outlook remains a concern: a comparison with PepsiCo highlighted rising costs and tight dividend coverage as risks. Clorox and PepsiCo dividend comparison
  • Negative Sentiment: Other reports cited ETF net selling and Barclays maintaining its sell rating, indicating continued institutional and analyst caution. ETF flows report Barclays rating report

Analyst Ratings Changes

A number of research firms have weighed in on CLX. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Clorox in a report on Tuesday, October 6th. BNP Paribas Exane lowered their target price on shares of Clorox from $97.00 to $95.00 and set a "neutral" rating on the stock in a research note on Monday, July 20th. JPMorgan Chase & Co. increased their target price on shares of Clorox from $83.00 to $86.00 and gave the stock an "underweight" rating in a research note on Tuesday. UBS Group set a $88.00 target price on Clorox in a research report on Tuesday. Finally, Wall Street Zen lowered Clorox from a "hold" rating to a "sell" rating in a research note on Saturday, October 3rd. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, Clorox presently has a consensus rating of "Reduce" and a consensus target price of $93.79.

Get Our Latest Analysis on CLX

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in CLX. Fifth Third Bancorp increased its holdings in Clorox by 10.0% in the 3rd quarter. Fifth Third Bancorp now owns 51,518 shares of the company's stock worth $4,173,000 after acquiring an additional 4,669 shares in the last quarter. Maryland State Retirement & Pension System raised its position in Clorox by 11.4% during the third quarter. Maryland State Retirement & Pension System now owns 7,188 shares of the company's stock worth $582,000 after acquiring an additional 733 shares during the period. Jacobi Capital Management LLC raised its position in Clorox by 8.9% during the third quarter. Jacobi Capital Management LLC now owns 17,567 shares of the company's stock worth $1,423,000 after acquiring an additional 1,429 shares during the period. First Command Advisory Services Inc. lifted its holdings in Clorox by 1,800.0% during the third quarter. First Command Advisory Services Inc. now owns 950 shares of the company's stock valued at $77,000 after purchasing an additional 900 shares in the last quarter. Finally, Bahl & Gaynor LLC lifted its holdings in Clorox by 3.0% during the third quarter. Bahl & Gaynor LLC now owns 8,529 shares of the company's stock valued at $691,000 after purchasing an additional 245 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

About Clorox

(Get Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Clorox?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Clorox and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles